UI Pharmaceuticals successfully completes site registration in South Korea for manufacturing a gel formulation used as antineoplastic drug.

UI Pharmaceuticals collaborates with MimiVax to manufacture new Glioblastoma vaccine.

The University of Iowa College of Pharmacy is pleased to announce that UI Pharmaceuticals (UIP) has validated its new sterile processing facility.

The engineering and facilities team at UI Pharmaceuticals, the College of Pharmacy’s FDA-registered drug development and manufacturing organization, has been working on innovative ideas and solutions to overcome process and mechanical challenges with the College’s unique pharmaceutical fill-line equipment.